Clinical Trials
3 trialsNCT02954874 2026-06-03
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06671912 2026-06-02
LoTam
Alliance for Clinical Trials in Oncology
Phase 3 Suspended
NCT05379153 2026-05-11
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting